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HIV-1 subtype C from Indiahe predominant subtype throughout the course of the HIV-1 epidemic in India
regardless of the geographic region of the country. In an effort to understand the mechanism of subtype C
predominance in this country, we have investigated the in vitro replication ﬁtness and transmission
efﬁciency of HIV-1 subtypes A and C from India. Using a dual infection growth competition assay, we found
that primary HIV-1 subtype C isolates had higher overall relative ﬁtness in PBMC than subtype A primary
isolates. Moreover, in an ex vivo cervical tissue derived organ culture, subtype C isolates displayed higher
transmission efﬁciency across cervical mucosa than subtype A isolates. We found that higher ﬁtness of
subtype C was not due to a trans effect exerted by subtype C infected PBMC. A half genome A/C recombinant
clone in which the 3′ half of the viral genome of subtype A was replaced with the corresponding subtype C3′
half, had similar replicative ﬁtness as the parental subtype A. These results suggest that the higher replication
ﬁtness and transmission efﬁciency of subtype C virus compared to subtype A virus from India is most
probably not due to the envelope gene alone and may be due to genes present within the 5′ half of the viral
genome or to a more complex interaction between the genes located within the two halves of the viral
genome. These data provide a model to explain the asymmetric distribution of subtype C over other subtypes
in India.
© 2009 Elsevier Inc. All rights reserved.IntroductionHuman immunodeﬁciency virus-1 was introduced into the human
population through 3 separate cross-species transmissions from non-
human primates in Africa (Gao et al., 1999; McCutchan, 2006). Each of
these transmission events is represented by phylogenetic groups
termed Group M, Group O and Group N. HIV-1 Group M, which is
responsible for the global pandemic, is further subdivided into 9
genetic groups (A–D, F–H, J and K) called subtypes or clades, based on
sequence diversity in the env gene. Subtype C has now become the
most predominant HIV-1 variant and accounts for more than 56% of
HIV-1 infections worldwide (Travers et al., 2004). It is mainly
concentrated in South and Eastern Africa, India and China.
In India, HIV-1 has spread rapidly throughout the country where it
has been reported in nearly every major city. Heterosexual contact is
the major route of transmission. There are an estimated 2.5 million
people living with HIV-1 in India, 90–95% are subtype C infections andImmunology, Weill Medical
l rights reserved.5–10% are subtype A and B infections. Genetic analyses of HIV-1
circulating in India since its identiﬁcation indicate that the current
epidemic is the result of one or very few introductions of HIV-1 into
the country (Agnihotri et al., 2006; Jere et al., 2004; Kalpana et al.,
2004; Kurle et al., 2004; Shankarappa et al., 2001). Therefore the
preponderance of subtype C viruses cannot be explained by new and
continual introductions of HIV-1 subtype C into the country. While
there may be several factors contributing to subtype C predominance,
the asymmetric distribution of HIV-1 subtype C over other subtypes in
India suggests that there may be a biological basis for such
dissemination. Some explanations for the asymmetric distribution of
HIV-1 subtypes in India include: founder effects, human genetic
susceptibility and viral attributes such as transmission efﬁciency and
replication ﬁtness of different subtypes of HIV-1.
Fitness is an evolutionary term used to describe the ability of an
organism to reproduce and adapt to its particular environment
(Domingo and Holland, 1997). For RNA viruses, ﬁtness can be
estimated by the relative ability to produce stable infectious progeny
in a given environment (Domingo and Holland, 1997; Domingo et al.,
1997). HIV ﬁtness can be affected by any combination of factors
encountered during viral replication or host factors such as immune or
drug pressure (Bates et al., 2003; Rangel et al., 2003). Several studies
417M.A. Rodriguez et al. / Virology 385 (2009) 416–424have investigated HIV ﬁtness as it relates to drug resistance, disease
progression and pathogenesis and also the ﬁtness of HIV genetic
variants as they relate to transmission efﬁciency and the global
distribution of subtypes. The seminal study examining this issue
comes from the work of Quinones-Mateu et al. (2000). Using a dual
infection growth competition assay (GCA), they examined relative
ﬁtness of virus isolates obtained from slow and rapid progressors as
well as those representing R5 and X4 phenotypes. They found that
virus isolates from long term nonprogressors were outcompeted by
viruses from rapid progressors. Similarly, X4/syncytium inducing (SI)
viruses generally outcompeted R5/non-syncytium inducing (NSI)
viruses, although some exceptions were noted. This study also showed
that there is a correlation between ex vivo ﬁtness and disease
progression. HIV-1 isolates from progressive patients were shown to
be signiﬁcantly more ﬁt than HIV-1 isolates from long-term
survivors — in several cases independent of viral phenotype. This
study was valuable in demonstrating that ﬁtness valuesmay serve as a
predictor of progression to AIDS. With a few HIV-1 isolates they have
shown a difference in replication ﬁtness among several non-C
subtypes of HIV-1. However, given the limited number of experiments
and strains used in competitive studies between different subtypes, it
is not clear if a particular subtype of viruses has a clear advantagewith
respect to replication ﬁtness.
In a later study, Ball et al. (2003), compared the ex vivo ﬁtness of
CCR5-tropic HIV-1 isolates of subtype B from Brazil and US and
subtype C mostly from Africa. The assays were conducted in PBMC,
CD4+ T cells, macrophages and Langerhans cells using a dual infection
growth competition assay. All subtype C isolates were outcompeted
by subtype B isolates in all cell types, except in Langerhans cells. In
Langerhans cells, subtype C demonstrated competitive replication
efﬁciency against subtype B. This observation is important when one
considers the fact that Langerhans cells in the cervix have been
implicated for HIV-1 transmission across the cervical mucosa. This
study was useful in generalizing the relative ﬁtness of HIV-1 subtype
C virus, but is not sufﬁcient to characterize the ﬁtness of Indian type C
viruses due to the recent ﬁndings that they are genetically different
than most other subtype C found throughout the world. We and
others have shown that Indian subtype C sequences (CIN, C3) are
distinct from subtype C sequences from 23 other countries (Harris et
al., 2003; Lal, Chakrabarti, and Yang, 2005; Shankarappa et al., 2001).
Speciﬁc amino acid substitutions in env were found to be distinguish-
ing characteristics within the Indian type C lineage (Agnihotri et al.,
2006; Kalpana et al., 2004; Lal, Chakrabarti, and Yang, 2005;
Shankarappa et al., 2001). In this study we have compared the in
vitro replication ﬁtness between HIV-1 subtypes A and C from India in
PBMC using a GCA and the transmission efﬁciency across cervical
mucosa using a cervical tissue derived organ culture. HIV-1 subtype A
primary isolates were outcompeted by HIV-1 subtype C primary
isolates in PBMC obtained from six US and two Indian donors.
Furthermore, most of the subtype C had higher transmissionTable 1
Indian patient information and virus characteristics
Isolate ID# Age Sex City of isolation Clinical symptoms
pIndieC1 ND ND ND ND
C31 25 F Calcutta Abdomen pain, diar
C59 16 F Calcutta Weakness, anorexia
C267 25 F Calcutta Abdomen pain, leuc
C298 24 F Calcutta N/A
A3 23 M Pune Asymptomatic
A6 30 M Pune Asymptomatic
A11 23 F Pune Asymptomatic
A15 16 F Calcutta Sore throat, weight
A81 45 M Pune Asymptomatic
ND or N/A — not determined, information unavailable; R5 — CCR5 coreceptor, NSI — non-syefﬁciencies than subtype A when cervical tissues were challenged
with a mixture of subtype A and subtype C viruses.
Results
Characterization of HIV-1 isolates and subtype determination
All of the viruses used for this study were obtained from HIV-1
infected individuals from India. Primary HIV-1 subtype A isolates A3–
A81 were obtained from Pune, a city in the southwest region of India,
while primary HIV-1 subtype C isolates C31–C298 and subtype A
isolate A15 were obtained from Calcutta, a major city in the eastern
region of India. All of the patients fromwhom HIV-1 was isolated had
no AIDS deﬁning symptoms and were drug naïve. A summary of
patient information and viral characteristics is shown in Table 1. HIV-1
subtypes were assigned to each of the isolates based on DNA
sequences within the env and gag genes and the LTR as described
previously (Rodriguez et al., 2006, 2007). To determine the coreceptor
usage, U87.CD4 cells expressing either the CXCR4 or CCR5 coreceptors
were infectedwith virus supernatant and virus growthwasmonitored
by measuring p24 antigen in the culture supernatant. All of the
primary isolates used in this study replicated more efﬁciently in U87.
CD4 cells expressing CCR5 than CXCR4, indicating that they are all R5
tropic viruses. The fold difference of CCR5 over CXCR4 growth was 80-
to 100-fold and the HIV p24 values in U87.CD4.CXCR4 cells were
mostly below 300 pg/ml. Consistent with CCR5 coreceptor usage, all
isolates were found to be non-syncytia inducing (NSI) due to their
inability to form syncytia in MT2 cells.
Standardization of HIV-1 RNA quantitation
To quantify the viral RNA concentration in dually infected cultures
we have standardized a subtype-speciﬁc real-time RTPCR that can
quantify subtype A and subtype C in a mixture of these two subtypes.
Using a number of TaqMan® cycling conditions, proviral DNA from
subtype A and C infected PBMC and several primer–probe pairs, we
were able to obtain gag primer pairs and cycling conditions which
could distinguish between and speciﬁcally amplify both subtypes.
Fig. 1A shows that using TaqMan® PCR cycling conditions, subtype C
primers only ampliﬁed the HIV-1 subtype C proviral DNA. Likewise,
subtype A primers only ampliﬁed HIV-1 subtype A proviral DNA.
Based on these results we constructed standard curves to quantitate
the relative proportion of viral variants in dual infections using full
length molecular clones of HIV-1 subtype A and C. Each plasmid clone
was serially diluted from 106 to 1 copy per reaction and analyzed in
triplicate. Fig. 1B shows that the assay had a linear range of detection
from 101 to 106 copies/ml of subtype C and subtype A and the
ampliﬁcation efﬁciency for each subtype speciﬁc primer set was
nearly identical. Furthermore, we observed that in a mixture of
subtype A and C proviral or plasmid DNA, both primer sets were ableCD4 count Subtype Coreceptor Phenotype
N/A C R5 NSI
rhea 343 C R5 NSI
736 C R5 NSI
orrhoea 255 C R5 NSI
233 C R5 NSI
N/A A R5 NSI
N/A A R5 NSI
905 A R5 NSI
loss 477 A R5 NSI
N/A A R5 NSI
ncytia inducing.
Fig. 1. Optimization of primers and probes for TaqMan® real-time PCR for detection of
subtypes A and C in a GCA. A) Gel image of PCR products generated using subtype A or
subtype C proviral DNA and subtype-speciﬁc primers. C-F/R and A-F/R indicate subtype C
or subtype A speciﬁc primers used in the PCR reaction (respectively). Lanes 1–11, each
lane represents proviral DNA fromPBMC infectedwith different HIV-1 subtype C viruses.
Lanes 12–16, each lane represents proviral DNA from PBMC infectedwith different HIV-1
subtype A viruses. B) Standard curves of subtype A and subtype C. Oval indicates a real-
time PCR assay in which primers and probes were tested by combining 5×105 copies of
HIV-1 subtype A and C plasmid DNA. Ct value=Cycle threshold value. 1 copy/ml is the
limit of detection for subtypeAprimers. C) Two andhalfmicroliters of genomicDNA from
subtype A or subtype C infected PBMC were either alone (dark bar) or mixed together
(shaded bar) followed by determination of the number of copies of each subtype in the
mixture by real-time PCRusing subtype A speciﬁc primer pairs (top panel) and subtype C
speciﬁc primer pairs (bottom panel). The DNA pairings in a mixture were as follows:
C267+A3; C31+A6; C59+A11; C298+A81. The total number of proviral DNA copies
detected alone compared to the number of copies detected in a mixture is shown.
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tion efﬁciencies (Figs. 1C and B, respectively).
Estimation of viral ﬁtness in PBMC by GCA
It has been well established that the best way of detecting
differences in replicative ﬁtness of two virus variants is by dual
infection growth competition assays (GCA). This is due to the fact that
these assays provide an internal control for the growth environment
and is better able to detect smaller differences in ﬁtness than
monoinfections (Quinones-Mateu and Arts, 2006). Several methods
have been employed to estimate the ﬁtness of viral variants in GCA. It
has been recently shown that TaqMan® real-time PCR is a suitable
method of detection and quantiﬁcation of two competing HIV-1
variants in a GCA and is less labor intensive and more sensitive than
previously used techniques such as HTA (Weber et al., 2003).
Therefore, in our study we have applied the TaqMan® real-time
RTPCR technique to estimate the viral ﬁtness of subtype A and C from
India in a GCA.Fig. 2. Representative GCA showing relative copy numbers of subtype A (A6) and C (C59)
isolates in monoinfections and dual infections determined by TaqMan real-time PCR.
Squares=subtype C, Diamond=subtype A. Single square at day 7 of 0.1:1 TCID50 ratio
indicates equal number of copies for subtype A and C. Relative RNA copy numbers were
calculated based on the average RNA copy number from duplicate experiments.
Fig. 3. Summary of relative copy numbers of all GCA's performed using PBMC fromUS donors at days 7 and 14 and 1:1 and 1:0.1 (A:C) TCID50 ratios. Relative HIV-1 RNA copy numbers
are expressed as log base 10 values. Line indicates log base 10 value of the mean of the RNA copy numbers.
Table 2
Relative ﬁtness and relative ﬁtness fold difference values of day 7 GCA using PBMC from
US donors
GCA pairs Relative WAa Relative WCa Relative WD(A/C)b Relative WD(C/A)b
A6:C31 0.67±0.12 2.17±0.83 0.31 3.26
A11:C31 0.23±0.01 4.57±0.03 0.05 19.92
A15:C31 0.05±0.03 5.64±0.14 0.01 107.77
A6:C59 0.32±0.01 3.46±0.09 0.09 10.94
A11:C59 0.17±0.17 4.86±1.07 0.04 28.50
A15:C59 0.04±0.01 5.65±0.08 0.01 137.91
A3:C267 0.05±0.02 5.61±0.12 0.01 110.37
A15:C267 0.37 2.89 0.13 7.88
A15:C298 0.20 4.43 0.05 21.82
A3:pInC1 1.02±0.14 1.01±0.19 1.00 1.00
A81:pInC1 0.43±0.07 3.01±0.29 0.14 7.08
p1579A-1:pInC1 0.49 1.51 0.32 3.08
a Relative ﬁtness w= f0/i0, where: f0=ﬁnal ratio of virus produced in dual infections
and i0= initial ratio of virus isolate in the inoculum. Relative ﬁtness values are based on
1:1 and 1:0.1 TCID50 ratios, ±standard deviation at 1:1 and 1:0.1 TCID50 ratios.
b Fitness difference (fold difference)WD=WM/WL, where:WM=relative ﬁtness of the
more ﬁt variant and WL=relative ﬁtness of the less ﬁt variant. GCA between a HIV-1
subtype A and subtype C molecular clone is indicated by p1579A-1:pInC1. The relative
ﬁtness value for p1579A-1:pInC1 GCA is shown for day 14 since on day 7 there was no
difference in the relative virus production.
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using ﬁve subtype C isolates (four primary and one molecular clone)
and ﬁve subtype A isolates (four primary and one molecular clone).
These competitions were performed in various combinations in six
different blood donors. In these assays CD8-depleted PBMC from US
blood bank donors were either dually or singly infected with each
virus subtype at varying TCID50 ratios. The proportion of each
variant in the culture supernatant was measured every 7 days by
TaqMan® real-time PCR. Fig. 2 shows a representative GCA, showing
the HIV-1 RNA concentration in monoinfections (Panel A) and in
dual infections of subtype A and C at both 1:1 (Panel B) and 1:0.1
(Panel C) TCID50 ratios, respectively at days 7 and 14 after infection.
At both of these 2 days tested, there was no signiﬁcant difference in
the relative copy numbers in monoinfections, while in dual
infections subtype C clearly outcompeted subtype A by day 7 at
1:1 TCID50 ratio and by day 14 at 1:0.1 (A:C) TCID50 ratio. Similar
results were observed in all other competitions between subtype A
and C. Fig. 3 shows a summary of all GCAs performed with subtype
A and C at days 7 and 14 at a 1:1 (Panels A and B) and 1:0.1 (A:C) (C
and D) TCID50 ratio. The data indicate that there was a signiﬁcant
difference in the RNA copy number of subtype C isolates compared
to subtype A isolates at both 1:1 and 1:0.1 (A:C) TCID50 ratios (D7
pb0.001, D14 pb0.001). Table 2 shows the estimated relative ﬁtness
values (w) and ﬁtness difference (WD) (see Materials and methods
for calculation of WD and w) for each pair of isolates used in the
GCA at day 7. With the exception of pIndieC1 in competition with
the primary isolate A3, all subtype C viruses had a ﬁtness difference
value that was at least 3-fold higher than subtype A viruses. At day
7 the mean WD for all subtype C viruses tested was 41.5 with a
range of 1.00–137.91, while the mean WD for all subtype A viruses
tested was 0.2 with a range of 0.00–0.32. Similar results were
obtained at day 14. The mean WD for subtype C viruses at day 14
was 57.8 with a range of 0.4–226.4, while the mean WD for subtype
A viruses at day 14 was 0.4 with a range of 0.0–2.7 (data not
shown). Overall the mean WD for subtype C viruses at all timepointsfor both TCID50 ratios was 58.4 with a range of 0.6–261.3, while the
overall mean WD for subtype A viruses was 0.2 with a range of 0.0–
1.5.
We also compared the replication ﬁtness of subtype A and C
viruses between PBMC from US and Indian donors. For this purpose
we ﬁrst examined the kinetics of viral replication in monoinfections of
PHA-stimulated PBMC from 13 Indian blood donors and 6 US blood
donors. Our results showed no signiﬁcant difference (pN0.05) in the
replication kinetics of subtype A and C viruses when PBMCs from US
and Indian blood donors were monoinfected (data not shown). We
then performed GCAs using PBMC from 2 Indian donors and 3 pairs of
subtype A and C viruses with known degrees of ﬁtness differences in
Table 3
Relative ﬁtness and relative ﬁtness fold difference values of day 7 GCA using PBMC from
Indian donors
GCA
pairs
Relative
WA
a
Relative
WC
a
Relative
WD(A/C)
b
Relative
WD(C/A)
b
Indian Donor 1 A6:C31 0.64±0.03 1.34±0.24 0.45 2.22
A15:C31 0.33±0.33 3.16±2.87 0.10 9.52
A11:C59 0.22±0.24 4.07±2.04 0.05 18.37
Indian Donor 2 A6:C31 0.54±0.07 2.37±0.21 0.23 4.37
A15:C31 0.20±0.08 4.52±0.65 0.04 23.07
A11:C59 0.16±0.01 4.63±0.04 0.03 29.73
Relative ﬁtness values (W) and ﬁtness fold difference values (WD) were calculated as
described for Table 2.
Fig. 4. Transmission efﬁciency of subtypes A and C primary isolates across cervical
mucosa. Transmission efﬁciencies are expressed as ﬁtness difference (fold difference).
WD has been calculated as described in Table 2.
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C outcompeted subtype A among all three pairs tested. Moreover, our
results showed that there was no signiﬁcant difference in the overall
WD values between US donors and Indian donor 1 (p=0.39, Student t-
test) or US donors and Indian donor 2 (p=0.45, Student t-test) in GCAs
(Tables 2–3). There was also no signiﬁcant difference in ﬁtness
between Indian donors 1 and 2 (p=0.12, Student t-test). We did,
however, observe a considerable difference in replication ﬁtness
among US donor 1 and both Indian donors for the 1579A vs C31
competition pair at day 7. In this group, the WD for US donor 1 was
107.77 while the WD in Indian donors 1 and 2 were 9.52 and 23.07,
respectively. This variability is not surprising considering that PBMC
from each individual will support different levels of virus replication.
But evenwith this variation the overall, replication ﬁtness of subtype C
was higher than subtype A in PBMC from US and Indian blood donors.
Replication ﬁtness and transmission efﬁciency of subtype A and C viruses
using an ex vivo organ culture
The preponderance of adult HIV-1 infections in India is due to
heterosexual contact. Using a cervical tissue-derived organ culture we
investigated the transmission across cervical mucosa of subtype A and
C virus by dually infecting cervical tissue with either primary isolates
or molecularly cloned HIV-1. After 3 days of exposure the level of
transmitted virus across the cervical mucosa into the bottom well
supernatant was measured by TaqMan® real-time RTPCR. Our results
show that in 4 out of 6 primary isolate pairs tested, in 6 different
cervical tissue specimens, subtype C virus had higher transmission
efﬁciency (replication ﬁtness) than subtype A virus (Fig. 4). TheWD for
subtype C viruses ranged from 0.72–47.03, while theWD for subtype A
viruses ranged from 0.02–1.49. For two transmission pairs, A11:C31
and A6:C31 subtype A showed slightly higher transmission efﬁciency
than subtype C. However, the subtypeAWD values for A11 andA6were
relatively low (range 1.31–1.49) compared to theWD values for subtype
C isolates (range 1.79–47.03) which showed higher transmission
efﬁciency than subtype A. The subtype C primary isolate C31, which
was outcompeted by subtype A in cervical tissue, also had the lowest
WD value in PBMC GCA (Table 2). These ﬁndings imply that subtype C
has higher overall transmission efﬁciency than subtype A although in
some cases subtype A may be better transmitted.
Investigation of a trans suppressive mechanism of subtype A replication
by subtype C in in vitro GCA
As discussed above we have observed that HIV-1 subtype C
outcompeted HIV-1 subtype A in GCA's. We investigated the
possibility of whether such competition of subtype A by subtype C
virus is mediated through a trans suppressive mechanism of subtype
A by a soluble factor secreted by subtype C infected cells. We tested
this by growing subtype A virus in the presence of virus-free culture
supernatant from subtype C-infected cells with or without pre-
treatment with such culture supernatant. We observed that virus-freeculture supernatant from monoinfected subtype C PBMC did not
suppress the growth of subtype A, regardless of whether the cells
were preincubated with the culture supernatant (Fig. 5). In fact, the
subtype C virus-free culture supernatant induced non-speciﬁc activa-
tion of cells and promoted increased growth of subtype A virus
compared to cells infected with subtype A virus and cultured in IL-2
media only. As a control, virus-free culture supernatant from subtype
A infected cells also did not suppress growth of subtype A virus, but
rather promoted increased growth of subtype A virus. Such activation
of viral growth did not occur in the presence of cell culture
supernatant from uninfected cells. These results indicate that soluble
factors such as gag matrix proteins or capsid protein which are
produced in abundance fromvirus infected cells such as those infected
by subtype C virus are not responsible for competitive growth of HIV-1
subtype C over subtype A in the GCA.
Determination of HIV-1 genomic regions responsible for enhanced
replication ﬁtness
There are reports which suggest that replication ﬁtness may be
mediated by the viral envelope gene (Ball et al., 2003; Marozsan et al.,
2005; Rangel et al., 2003). To investigate this possibility we
constructed half genome chimeric virus by replacing the 3′ half (tat-
3′ LTR) of an HIV-1 subtype A molecular clone (p1579A-1) with an
equivalent 3′ half of a subtype C clone (pIndieC1) from India to
generate a full length A/C chimeric clone as described in the Materials
and methods section. The A/C chimeric virus was then tested against
the parental subtype A virus in a GCA using PBMC. As shown in Fig. 6,
at day 14 as expected, subtype C pIndieC1 outcompeted subtype A
p1579A-1 by at least 3-fold. However the A/C chimeric clone had
similar, albeit slightly lower replication ﬁtness than p1579A-1 in the
GCA. These results would suggest that genomic elements in the 3′ half
of subtype C are not solely attributable to replication ﬁtness
differences between subtype A and C virus of Indian origin. These
results suggest that the higher replicative ﬁtness of subtype C over
subtype A may be due to genes located at the 5′ half of the viral
genome or to a more complex interaction between the genes located
within both halves of the viral genome.
Discussion
There is a growing body of data supporting the hypothesis that the
differential spread of HIV variants, groups and subtypes in the human
population may be related to differences in replication ﬁtness (i.e.
replicative capacity) and transmission efﬁciency (Arien et al., 2005;
Ball et al., 2003; John-Stewart et al., 2005; Konings et al., 2006;
Quinones-Mateu et al., 2000). The study reported by Quinones-Mateu
et al. (2000), observed a correlation between ex vivo ﬁtness and
Fig. 5. Trans suppression of HIV-1 subtype A by virus-free supernatant from infected cells or by culture supernatant from uninfected cells. Cells were either pre-treated with virus-
free supernatant or not pre-treated, followed by infectionwith HIV-1 subtype A then cultured in the presence of increasing concentrations of the same virus-free supernatant. At day
7, culture supernatants were tested for HIV-1 p24 antigen production. Infect only indicates cells that were infectedwith HIV-1 subtype A and not pre-treated or grown in the presence
of virus-free supernatant. Negative controls included 1) pre-treatment, culture in the presence of virus-free supernatant and no infection; 2) no pre-treatment, culture in the
presence of virus-free supernatant and no infection and 3) cells only, no infection. All negative controls showed no virus growth as determined by HIV-1 p24 assay (p24≤30 pg/ml at
day 14, data not shown).
Fig. 6. Replication ﬁtness fold difference of parental subtype A and subtype C and half
genome A/C chimera viruses at a 1:1 TCID50 ratio for Day 14 of a GCA. A schematic
representation of HIV-1 parental and half-genome clones is shown below the graph.
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replicative ﬁtness data can be used to study the interaction between
two subtypes in transmission and disease progression.
Recently using a GCA assay, Arien et al. (2005) assigned an order of
relative ﬁtness to all classes of HIV viruses: HIV-1 group MNHIV-
2NHIV-1 group O. This study implied that the lower replicative
capacity of group O and HIV-2 compared to group M viruses may have
led to decreased transmission and distribution of these groups in the
human population. In a recent study, ex vivo replicative ﬁtness of
CRF02_AG isolates was found to be higher than subtype A and G
viruses from the same geographic region and was independent of the
coreceptor tropism and irrespective of high or low CD4+T cell counts
(Njai et al., 2006). Over the last 10 years CRF02_AG has become the
predominant subtype in West and West Central Africa. These results
suggest that replicative ﬁtness may have contributed to the dominant
spread of CRF02_AG over A and G subtypes in West and West Central
Africa (Njai et al., 2006).
Genetic analysis of HIV-1 circulating in different parts of India at
different times in the last 15 years indicates that subtype C
predominates in India with a small proportion of infection caused
by subtypes A or B (Baskar et al., 1994; Delwart et al., 1993; Maitra et
al., 1999; Shankarappa et al., 2001; Tripathy et al., 1996). These Indian
HIV-1 are of CCR5 tropism with a NSI phenotype even when they are
isolated at late stages of infection (Cecilia et al., 2000; Shankarappa et
al., 2001). Additionally, we have shown that HIV-1 subtype C from
India is genetically distinct from other HIV-1 subtype C around the
world, like those from Africa and South America (Agnihotri et al.,
2006; Jere et al., 2004; Kalpana et al., 2004; Shankarappa et al., 2001).
HIV-1 infection in some parts of Africa initiated primarily with
subtype C, but later other non-C subtypes emerged to account for as
much as 40% of circulating subtypes in that region. In contrast, HIV-1
subtype C in India has predominated over other subtypes throughout
the entire epidemic and regardless of the geographic area (Baskar et
al., 1994; Delwart et al., 1993; Jameel et al., 1995; Maitra et al., 1999;Sengupta et al., 2005; Shankarappa et al., 2001; Tripathy et al., 1996).
Our results indicate that PBMC from the Indian population do not
support higher replication of subtype C as compared to subtype A of
Indian origin, indicating that genetics of the Indian population may
not be responsible for the asymmetric distribution of subtype C over
other subtypes in India. This distinct asymmetric distribution of HIV-1
subtypes in India suggests that there may be a biological basis for such
dissemination. The mechanism for such an asymmetric distribution
could be due to any one or combination of factors including replication
ﬁtness, transmission efﬁciency and founder effect. In this report we
have examined the ﬁrst two possibilities using subtype A and C from
India.
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replicative ﬁtness among these two subtypes. Our data indicate that
among eleven out of twelve subtype A and C pairs tested, all primary
subtype C isolates had higher replicative ﬁtness (mean ﬁtness
difference score of 57.7) than subtype A isolates when cells were
dually infected at a ratio of 1:1. Even at 10-fold less inoculum than
subtype A, subtype C isolates outcompeted subtype A in most cases.
These results demonstrate that subtype C HIV-1 isolates from India
have higher replicative ﬁtness than subtype A from India in PBMC.
Such replicative ﬁtness of subtype C over subtype A also has been
extended to PBMC of Indian origin, indicating that such replicative
ﬁtness of subtype C is independent of ethnic origin. These data
contradict previous ﬁndings that subtype C is the least ﬁt among
groupM subtypes (Arien et al., 2005). This could be due to the fact that
Indian subtype C is genetically different than subtype C from other
countries (Shankarappa et al., 2001) and therefore subtype Cs from
India may represent a HIV-1 type C subset that has atypical replication
ﬁtness characteristics compared to type C from other countries.
Similarly, subtype As from India may represent a HIV-1 type A subset
with impaired ﬁtness compared to other type As. Furthermore our
results are consistent with ﬁndings that subtype Cmay have similar or
in some cases enhanced transmissibility compared to other subtypes
(Arien et al., 2006; Ball et al., 2003). This study represents the ﬁrst
comprehensive panel of primary HIV-1 subtype A and C viruses from
India examined for replication ﬁtness differences and should serve as
an example of the intrasubtype variability that may be found within a
particular region in the world.
Since Langerhans cells in cervical mucosa have been implicated for
HIV-1 transmission across cervicovaginal mucosa, we examined
replicative ﬁtness between subtype A and subtype C from India in a
cervical tissue derived organ culture. Use of a cervical tissue derived
organ culture provides direct measurement of HIV transmission across
the cervical mucosa. Our data indicate that in 4 out of 6 pairs tested,
subtype C had higher transmission efﬁciencies than subtype A. Two
pairs (A6:C31 and A11:C31) in which subtype C had shown lower
transmission efﬁciency than subtype A, also showed relatively lower
replicative ﬁtness scores (3.3 and 19.92, respectively) in PBMC as
compared to other competing pairs (mean 46.69). These observations
along with a recent report demonstrating a correlation between
subtype C infected women and increased vaginal shedding of virus
(John-Stewart et al., 2005) and another describing compartmentaliza-
tion of subtype C virus in the cervix of a woman dually infected with
subtype A and C viruses (Iversen et al., 2005), indicate that subtype C
may have transmission advantages which could have inﬂuenced its
spread throughout India and regions of Africa.
To understand the molecular mechanism of higher in vitro
replicative ﬁtness of subtype C over subtype A, we have examined a
trans mechanism for higher replication ﬁtness of subtype C in which
a soluble factor(s) secreted by subtype C infected cells could confer
suppression of subtype A replication. Our data indicate that virus-free
culture supernatant from monoinfected subtype C PBMC did not
suppress the growth of subtype A, regardless of whether the cells
were preincubated with the culture supernatant or not. In fact, the
subtype C virus-free culture supernatant induced non-speciﬁc activa-
tion of cells and promoted increased growth of subtype A compared to
cells infected with subtype A and cultured in IL-2 media only.
We examined the role of LTR and envelope gene to elucidate a
cis mechanism of higher replicative ﬁtness of subtype C over
subtype A. In a previous study we have shown that there was no
signiﬁcant difference in the structure and function of the LTR
between subtypes A and C from India even though subtype C was
predicted to have an additional NF-κB site (Rodriguez et al., 2007).
To understand the role of envelope gene, we have constructed a
recombinant between subtype A and subtype C in which the 3′ half
of the subtype A genome has been replaced with subtype C. A
competition between this recombinant and the parental wild typesubtype A in a GCA assay indicate that the genes present within the
3′ half of the genome, like env gene, are not directly responsible for
differences in replication ﬁtness between subtype C and subtype A.
It is possible that genes present at the 5′ end of the viral genome or
a more complex interaction between the genes located within both
halves of the viral genome may be responsible for differences in
replication between these subtypes. The data supporting a correla-
tion between in vitro viral replication ﬁtness in PBMC and the global
distribution and epidemiologic spread of HIV is continuously
expanding. Our investigation sheds new light on the potential role
of replication ﬁtness and transmission efﬁciency on the asymmetric
distribution of HIV-1 subtypes in India. This study also shows that
HIV-1 subtypes with higher ﬁtness could have a replication
advantage over other subtypes which may shape the epidemic
and current global subtype distribution.
Materials and methods
Viruses
Five primary isolates (C31, C59, C267, C298 and 1579A) were
isolated from PBMC of HIV-1-infected subjects at Chittaranjan Cancer
Research Institute in Calcutta, India. Virus isolation was performed as
described previously (Balachandran et al., 1988, 1991). Brieﬂy, PBMC
from HIV-infected Indian patients were cultured in the presence of
phytohemagglutinin (PHA)-stimulated, CD8-depleted normal donor
PBMC in RPMI 1640 media supplemented with IL-2. Virus growth was
monitored by HIV-1 p24 production in the culture supernatant. Virus
supernatant was harvested every 5 days for 40 days. Harvested virus
was expanded in phytohemagglutinin (PHA)-stimulated, CD8
depleted normal donor PBMC in RPMI 1640 media supplemented
with IL-2 as described previously (Rodriguez et al., 2006). Four other
primary subtype A isolates (A3, A6, A11 and A81) were obtained from
the National AIDS Research Institute in Pune, India. Virus isolationwas
performed as described previously (Kulkarni et al., 1999). In addition,
the HIV-1 infectious molecular clone IndieC1 was obtained from the
molecular clone pIndieC1 kindly provided by Dr. M. Tatsumi
(Mochizuki et al., 1999). Coreceptor usage and MT2 assay for syncytia
formation were conducted as described previously (Rodriguez et al.,
2006). The infectivity titer for each isolate was determined by
measuring HIV p24 production after 7 days using an endpoint dilution
assay. The tissue culture dose for 50% infectivity (TCID50) was
calculated using the Spearman–Karber formula.
GCA
PBMC were puriﬁed from 5 US blood bank donors (racial and
ethnic backgrounds unknown) and 2 Indian donors (IRB approved)
by Ficoll–Hypaque density centrifugation. CD8 depleted PBMC
isolated from PBMC using immunomagentic beads were stimulated
overnight with PHA and treated with 5 μg/ml polybrene for 1 h
prior to infection. For each GCA, 3×105 PHA-stimulated cells were
infected either singly or dually with subtype A and C viruses at
TCID50 ratios of 1:1 or 1:0.1 at 37 °C overnight in a 48-well plate.
The next day the cells were pelleted and the virus supernatant was
removed. The cell pellet was then resuspended in 750 μl IL-2 media
and divided equally between three wells (100,000 cells/well) in a
96-well plate. The TCID50 for each primary isolate pair in a dual
infection ranged from 2×104 to 2×105. This gives an MOI range of
0.06 to 0.6. All competition experiments were performed in
duplicate. One hundred microliters of cell free supernatant was
collected at 7, 14 and 21 days and analyzed for the level of subtype
speciﬁc RNA by real-time PCR. Virus growth was monitored every
7 days by measuring HIV-1 p24 antigen in the culture supernatant.
There was no bias in the selection of subtype A or C viruses used in
this study. The only prerequisite was that the viruses have an
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infectivity and replication properties of the virus upon further
dilution. There was also no selection bias for the combinations
chosen for each GCA, however those subtype A and C viruses that
had the most similar infectivity titers were paired to avoid further
dilution.
Organ culture
Ectocervical tissues were obtained from HIV seronegative pre-
menopausal women with no history of STD's or cancer, undergoing
hysterectomy or anterior/posterior repair procedures. The organ
culture was set up as previously described (Collins et al., 2000).
Brieﬂy, a 6 mm biopsied cervical tissue was placed into the transwell
with the epithelial layer oriented upwards and sealed around its
perimeter with 3% agarose. The tissue containing Transwell was then
placed into a 12-well plate containing 1 ml of RPMI-1640 media
supplemented with 10% FBS. A Transwell with the membrane only
served as a positive control while a Transwell with agarose only
served as a negative control. To study the transmission of virus, 150 μl
of cell-free HIV-1 subtype A and C virus either alone ormixed at a ratio
of 1:1, was added to the tissue containing well and the positive and
negative control wells, and incubated at 37 °C for 3 days. Each
transmission pair was tested in at least triplicate. On the third day, the
tissue was removed and the culture supernatant in the bottom
chamber was centrifuged at high speed (22,000 rpm) to pellet the
transmitted virus. The level of subtype speciﬁc HIV-1 RNA in the pellet
was quantitated using TaqMan® real-time RTPCR. To ensure that
transmitted virus was not due to leaks in the system at the end of each
experiment the intactness of the tissue was evaluated by examining
transmission of blue dextran through the tissue and agarose control
wells.
RTPCR and TaqMan® real-time PCR
To quantify the relative proportion of HIV-1 subtype A and C in
culture ﬂuid of GCA or transmission studies, subtype speciﬁc
primers for the gag-p17 region of the genome were used in a
TaqMan® real-time PCR assay. Standard curves from 106 to 1 copy
were generated using p1579A-1 or pIndieC1 molecular clones
(Mochizuki et al., 1999). The concentrations of the clones were
determined by spectrometry at 260 nm. The subtype A speciﬁc
primers used were gagAF153–178 (5′-CTGGTGAGTACGCCAATTTTTG-
3′) and gagAR276-258 (5′-CCCCTGGCCTTAACCGAAT-3′). The subtype
C speciﬁc primers used were gagCF150–174 (5′-CGACTGGTGAG-
TACGCCAATTTTA-3′) and gagCR270–243 (5′-GCCTTAACC-
TAATTTTTTCCCATTTATC-3′). The probe used was universal and
recognized by both subtype A and C variants; gagP-ﬂuorochrome
205–187 (5′-ATCTCTCTCCTTCTAGCCT-3′). 100–1000 μl culture super-
natant equivalent RNA was applied for reverse transcription using
TaqMan® reverse transcription reagents (Applied Biosystems)
according to the manufacturer's protocol. A 30 μl TaqMan® PCR
was performed by mixing 5 μl cDNA with TaqMan® Universal PCR
Master Mix (Applied Biosystems), 333 nM each of forward and
reverse primer and 250 nM FAM/MGB labeled probe. ABI Prism
7000 Sequence Detection System was used to carry out Real-Time
PCR using the following cycling condition: 50 °C for 2 min, 95 °C for
10 min, 45 cycles of 95 °C for 15 s and 60 °C for 1 min. Serial diluted
plasmid DNA ranging from 1 to 106 copies were applied to each PCR
assay for a standard curve. A no template control was included in
each assay as well to guard against cross contamination. Each
sample was run in triplicate. ABS Prism 7000 SDS Software
(AppliedBiosystems) was used for PCR data analysis and HIV copy
number estimation. To quantify the relative proportion of half-
genome A/C recombinant virus and parental subtype C virus using
TaqMan® real-time RTPCR, gag subtype-speciﬁc primers and gaguniversal probe was used. To quantify parental p1579A virus and
half-genome A/C recombinant virus, envelope gene subtype speciﬁc
primers and probes were used. The env subtype A speciﬁc primers
used were 1579A-F (5′-TCTGTGTCACTTTAAATTGTAGCAATGT-3′) and
1579A-R (5′-TCTGTGGTCATATTGAAAGTGCAGTT-3′). The env subtype
A speciﬁc probe used was 1579A-P (5′-TTTACTTCCTGTGTGTTATT-3′).
The subtype C speciﬁc primers used were IndC1-F (5′-CAAAGCC-
TAAAGCCATGTGTAAAA-3′) and IndC1-R (5′-GCTCCCATTGTAGGTAT-
TATAACTGCTA-3′). The subtype C speciﬁc probe used was IndC1-P
(5′-TCTGTGTCACTTTAGAATGTAGA-3′). Standard curves, reaction
conditions and cycling conditions were as described above for gag.
Construction of A/C half-genome recombinant virus
Construction of a half genome A/C recombinant clone involved use
of the available unique restrictions sites in the infectious molecular
clone of subtype A HIV-1 1579A. The 3′ half (tat-3′ LTR) of pIndieC1
was PCR ampliﬁed with a forward primer containing a BamHI site and
a reverse primer containing a BstEII site. The complete ﬁrst exon of
subtype C tat was included in the tat-3′ LTR fragment except for the
ﬁrst 2 amino acids which are subtype A tat. The entire 3′ LTR of
subtype C was also included in the fragment. Upon reverse transcrip-
tion, the subtype C LTR will become both the 5′ and 3′ LTR and
therefore will serve as the viral promoter. The integrity of the vpr
proteinwas not affected since the open reading framewas maintained
in the joined region. The vpr protein is from subtype A except the last
6 amino acids which are subtype C. Despite this the vpr protein
sequence is unchanged. The subtype C tat-3′ LTR PCR product was
subsequently subcloned into the pCR Blunt II TOPO vector (Invitro-
gen). All PCR reactions were carried out using the high ﬁdelity
AccuPrime Pfx DNA polymerase (Invitrogen). p1579A and the 3′ half of
pIndieC1 were digested with BamHI and BstEII and the corresponding
genomic halves were ligated together. The resulting full-length A/C
recombinant clones obtained from the ligation mixture were
sequenced within the joined region and several hundred bases
upstream and downstream of the joined region to ensure the identity
of the recombinant. DNA from these recombinants was then used in
the transfection of HEK293T cells followed by expansion of the virus
containing supernatant in CD8-depleted PBMC.
Estimation of viral ﬁtness
Viral ﬁtness was calculated by measuring relative viral RNA
concentration of subtype A and C in culture supernatant as described
by Quinones-Mateu et al. (2000). Brieﬂy, the ﬁnal ratio of virus
produced in dual infections (f0) was divided by the initial ratio of virus
in the inoculum (i0) to derive a single relative ﬁtness (w) value (w= f0/
i0). An average relative ﬁtness value (wn) was estimated for each
variant in dual competitions, where wn=the average ﬁtness value for
each timepoint based on all TCID50 ratios. The ratio of relative ﬁtness
values of each HIV-1 variant in the competition is a measure of the
ﬁtness difference (WD) between both HIV-1 strains (WD=WM/WL),
where WM and WL correspond to the relative ﬁtness of the more and
less ﬁt viruses, respectively. A WDN1 corresponds to the variants
exhibiting higher ﬁtness. AWDb1 corresponds to the less ﬁt variant. A
WD=1 corresponds to equal ﬁtness of the two variants (Chao, 1990;
Quinones-Mateu et al., 2000).
Trans suppression assay
Culture supernatant from subtype C or A infected CD8-depleted
PBMC at day 15 was ﬁltered followed by depletion of virus by high
speed centrifugation at 22,000 rpm for 1 h at 4 °C. One-hundred
thousand CD8-depleted PBMC were then pre-treated with the virus-
free supernatant or cell culture supernatant from uninfected cells or
media for 4 h at 37 °C. After pre-treatment, the cells were spun down
424 M.A. Rodriguez et al. / Virology 385 (2009) 416–424and the supernatant removed. Pre-treated cells were infected with
200 μl of 3.8×106 TCID50/ml HIV-1 subtype A (∼30 ng p24 protein)
overnight in a 24-well plate. The next day the virus was removed and
the cells were resuspended in a ﬁnal volume of 0%, 20% or 50% virus-
free supernatant from subtype A or C infected cells. The ﬁnal culture
volume was brought up to 250 μl with RPMI-1640 media supple-
mented with IL-2. Virus growth was estimated by HIV-1 p24 in the
culture supernatant at day 7 post infection.
Statistical analysis
Average RNA copy numbers were calculated from each duplicate
virus in the competition. Two sample t-test of the copy numbermeans
and Mann–Whitney (nonparametric) were used for comparison of
subtype A group and subtype C group at day 7 and day 14, for
assessment of statistical signiﬁcance. WD values were calculated as
described above. One sample t-test was used to determine whether
the log relative WD was signiﬁcantly different from WD=0. For all
analyses, the level of signiﬁcance was set at p=0.05.
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